These findings further suggest that the hypothalamic damage occurring in AD may be associated with tau pathology, which may start indeed in the LC itself (Braak and Del Tredici 2011) (see “The occurrence of neuronal loss/degenerative phenomena and NE alterations in the hypothalamus of AD patients” section). This evidence concerns the gene MAPT and Alzheimer disease.